Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA approves Baxdela for ABSSSI

June 20, 2017

Next generation diarylquinoline TBAJ-587 displays superior potency against tuberculosis

June 20, 2017

Novel pocket-modified vancomycin analogues show potential as durable and potent antibiotics

June 20, 2017

Novartis presents data for the novel antibacterial agent LYS-228

June 19, 2017

Basilea Pharmaceutica presents new bacterial efflux pump inhibitors

June 19, 2017

Janssen R&D Ireland synthesizes new anti-influenza compounds

June 19, 2017

Pfizer gains European commercialization rights to Cresemba from Basilea

June 15, 2017

Abivax to receive loan to support development of Ebola hyperimmune candidate

June 15, 2017

Actelion presents preclinical data for novel bacterial topoisomerase inhibitor ACT-051

June 15, 2017

Cefepime/S-02030 combination efficacious in murine bacteremia model

June 15, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...